172 related articles for article (PubMed ID: 7130435)
1. Abnormal involuntary movements in schizophrenia: are they related to the disease process or its treatment? Are they associated with changes in dopamine receptors?
Crow TJ; Cross AJ; Johnstone EC; Owen F; Owens DG; Waddington JL
J Clin Psychopharmacol; 1982 Oct; 2(5):336-40. PubMed ID: 7130435
[TBL] [Abstract][Full Text] [Related]
2. Association of intellectual impairment, negative symptoms, and aging with tardive dyskinesia: clinical and animal studies.
Waddington JL; Youssef HA; Molloy AG; O'Boyle KM; Pugh MT
J Clin Psychiatry; 1985 Apr; 46(4 Pt 2):29-33. PubMed ID: 2858476
[TBL] [Abstract][Full Text] [Related]
3. Historical perspective on movement disorders.
Friedman JH
J Clin Psychiatry; 2004; 65 Suppl 9():3-8. PubMed ID: 15189105
[TBL] [Abstract][Full Text] [Related]
4. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
Bishnoi M; Chopra K; Kulkarni SK
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
[TBL] [Abstract][Full Text] [Related]
5. Abnormal neuroleptic/dopamine receptors in schizophrenia.
Lee T; Seeman P
Adv Biochem Psychopharmacol; 1980; 21():435-42. PubMed ID: 6103653
[TBL] [Abstract][Full Text] [Related]
6. Behavioral and biochemical correlates of the dyskinetic potential of dopaminergic agonists in the 6-OHDA lesioned rat.
Carta AR; Frau L; Pinna A; Pontis S; Simola N; Schintu N; Morelli M
Synapse; 2008 Jul; 62(7):524-33. PubMed ID: 18435422
[TBL] [Abstract][Full Text] [Related]
7. Stable remission of tardive dyskinesia by L-dopa.
Ludatscher JI
J Clin Psychopharmacol; 1989 Feb; 9(1):39-41. PubMed ID: 2565346
[TBL] [Abstract][Full Text] [Related]
8. Orofacial dyskinesia. Clinical features, mechanisms and drug therapy.
Kobayashi RM
West J Med; 1976 Oct; 125(4):277-88. PubMed ID: 23611
[TBL] [Abstract][Full Text] [Related]
9. Dopamine receptors and the dopamine hypothesis of schizophrenia.
Seeman P
Synapse; 1987; 1(2):133-52. PubMed ID: 2905529
[TBL] [Abstract][Full Text] [Related]
10. Tardive dyskinesia presenting as gastrointestinal disorder.
Goldberg RJ; Morris PL; Lidofsky S
J Clin Psychiatry; 1990 Jun; 51(6):253-4. PubMed ID: 1971823
[TBL] [Abstract][Full Text] [Related]
11. Involvement of adenosinergic receptor system in an animal model of tardive dyskinesia and associated behavioural, biochemical and neurochemical changes.
Bishnoi M; Chopra K; Kulkarni SK
Eur J Pharmacol; 2006 Dec; 552(1-3):55-66. PubMed ID: 17064683
[TBL] [Abstract][Full Text] [Related]
12. [Clinical aspects of tardive dyskinesias induced by neuroleptics].
Villeneuve A; Lajeunesse C
Encephale; 1988 Sep; 14 Spec No():209-14. PubMed ID: 2905648
[TBL] [Abstract][Full Text] [Related]
13. Brain dopamine receptors in schizophrenia and tardive dyskinesia.
Seeman P
Psychopharmacology Suppl; 1985; 2():1-8. PubMed ID: 3159008
[TBL] [Abstract][Full Text] [Related]
14. [Utility of quetiapine in tardive dyskinesia].
Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
[TBL] [Abstract][Full Text] [Related]
15. Association between the MnSOD Ala-9Val polymorphism and development of schizophrenia and abnormal involuntary movements in the Xhosa population.
Hitzeroth A; Niehaus DJ; Koen L; Botes WC; Deleuze JF; Warnich L
Prog Neuropsychopharmacol Biol Psychiatry; 2007 Apr; 31(3):664-72. PubMed ID: 17291655
[TBL] [Abstract][Full Text] [Related]
16. [Neuroleptic-induced movement disorders: historical perspectives].
Wolf MA; Yassa R; Llorca PM
Encephale; 1993; 19(6):657-61. PubMed ID: 12404786
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of spontaneous dyskinesia in schizophrenia.
Fenton WS
J Clin Psychiatry; 2000; 61 Suppl 4():10-4. PubMed ID: 10739325
[TBL] [Abstract][Full Text] [Related]
18. Bereitschaftspotential in tardive dyskinesia.
Adler LE; Pecevich M; Nagamoto H
Mov Disord; 1989; 4(2):105-12. PubMed ID: 2733704
[TBL] [Abstract][Full Text] [Related]
19. [Two cases of tardive Tourette syndrome].
Yamauchi K; Ohmori T
Seishin Shinkeigaku Zasshi; 2006; 108(5):459-65. PubMed ID: 16869393
[TBL] [Abstract][Full Text] [Related]
20. No difference in the effect of biperiden and amantadine on parkinsonian- and tardive dyskinesia-type involuntary movements: a double-blind crossover, placebo-controlled study in medicated chronic schizophrenic patients.
Silver H; Geraisy N; Schwartz M
J Clin Psychiatry; 1995 Apr; 56(4):167-70. PubMed ID: 7713856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
